Story perspectives

Trump Raises Drug Tariffs: Prices and Innovation at Risk

4/25/2025

39 5

Summary

Story summary

President Trump’s administration is raising tariffs on pharmaceuticals from 2.5% to nearly 25%.
Increased tariffs may drive up drug prices and worsen shortages, especially for generic manufacturers.
A national security investigation into pharmaceutical imports could result in additional tariffs.
Industry leaders caution that tariffs may stifle innovation and deter long-term domestic investments.
The U.S. dependence on foreign pharmaceutical imports complicates local manufacturing efforts.

History

Historical Context

President Trump's administration's decision to raise pharmaceutical tariffs from 2.5% to nearly 25% echoes historical protectionist policies, notably the Smoot-Hawley Tariff Act of 1930, which aimed to protect American industries but worsened the Great Depression. The current tariffs may similarly increase drug prices and shortages, reflecting ongoing tensions between domestic manufacturing and reliance on foreign imports, a long-standing issue in U.S. trade policy.

1 of 2

Story summary

President Trump’s administration is raising tariffs on pharmaceuticals from 2.5% to nearly 25%.
Increased tariffs may drive up drug prices and worsen shortages, especially for generic manufacturers.
A national security investigation into pharmaceutical imports could result in additional tariffs.
Industry leaders caution that tariffs may stifle innovation and deter long-term domestic investments.
The U.S. dependence on foreign pharmaceutical imports complicates local manufacturing efforts.

1 / 2